The company Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has disclosed its financial results for the first quarter of 2026.

In the period, the company achieved operating revenue of approximately 23.278 billion yuan, representing a year-on-year increase of 3.58%.

Net profit attributable to shareholders was 1.784 billion yuan, marking a decrease of 2.06% compared to the same period last year.

After adjusting for non-recurring gains and losses, the net profit attributable to shareholders was approximately 1.703 billion yuan, which reflects a growth of 1.72% year-on-year.